Terkur

Aluminium Chlorohydrate

Treatment option:

Medically reviewed

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Terkur

Property	Description
Active ingredient	Aluminium Chlorohydrate
Form	Cream (Krem)
Pharmacological class	Astringent, Antiperspirant
Common use	Management of excessive sweating (Hyperhidrosis)
Origin	Synthetic

What Type of Product is Terkur and Its Primary Classification?

Terkur is classified as a specialized topical antiperspirant agent, functioning as a dermal product intended for external use to manage excessive moisture. This preparation belongs to the functional pharmacological class of astringents, which are compounds that cause localized tissue constriction. The use of aluminum salts in this context is clinically recognized for controlling perspiration. As an over-the-counter (OTC) hygiene product, Terkur’s primary distinction is its targeted focus on providing a moisture-control solution for individuals experiencing hyperhidrosis.

Active Ingredient and Dermal Preparation Form

The sole active ingredient in Terkur is Aluminium Chlorohydrate, which is a synthetic substance, characterized chemically as a group of water-soluble aluminum complexes. This compound is a standard component in antiperspirant formulations detailing its mechanism of action. Terkur’s distinctive feature lies in its dosage form: it is formulated as a specialized cream (Krem), unlike many analogues which are often liquid solutions or sprays. This single-ingredient product utilizes the cream base to facilitate controlled, topical delivery of the active substance.

Terkur’s General Function and Management of Hyperhidrosis

The general function of Terkur is achieved through a physical mechanism where the aluminum complexes precipitate on the skin surface, primarily within the stratum corneum layer, forming a temporary obstruction. This temporary blockage is why aluminum salts are considered effective antiperspirants. This mechanism serves the overarching purpose of managing hyperhidrosis by reducing the amount of moisture reaching the skin’s surface. By physically limiting the sweat output, this antiperspirant agent also aids in controlling the wet environment that contributes to issues such as bacterial growth and associated koku yayılması (odor spread).

What side effects are possible with Terkur?

Possible Side Effects and Safety Information

The safety profile of Terkur (Aluminium Chlorohydrate), as established by official governmental regulatory requirements for Over-the-Counter (OTC) antiperspirant drug products, focuses primarily on localized application site reactions and mandatory constraints for use.

Officially Documented Adverse Reactions

The regulatory labeling for this active ingredient mandates that the most common adverse reactions requiring discontinuation of use are confined to the application site, classified as Skin and Subcutaneous Tissue Disorders.

Adverse Reaction	Regulatory Classification Context
Rash	Listed as a trigger for a mandatory 'Stop Use' warning.
Irritation	Listed as a trigger for a mandatory 'Stop Use' warning.

Formal frequency categories (e.g., Common, Rare) for these effects are not explicitly defined in the mandatory regulatory labeling.

High-Level Safety Constraints and Considerations

The official safety information includes specific restrictions and required warnings based on potential safety concerns beyond the local application site.

Population-Specific Consideration: A mandatory caution requires individuals with Kidney Disease to consult a doctor before use. This is due to the documented risk of aluminum accumulation in the presence of diminished renal function.
Site Restriction: Use is strictly prohibited on broken skin to minimize the risk of adverse effects and potential systemic exposure.
Discontinuation Requirement: The product must be discontinued immediately if rash or irritation develops at the site of application.

Connection to the Overall Safety Profile

The regulatory safety profile structures the understanding of potential risks by concentrating on preventing local skin damage and managing the risk of systemic exposure only in the specifically designated population of patients with impaired kidney function. This framework is primarily defined by the mandatory application constraints and required warnings.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory information for Terkur focuses on overdose risk from accidental oral ingestion, as systemic absorption is minimal with proper topical use. Any suspected or confirmed oral ingestion requires immediate attention.

Overdose Scope (Official Regulatory Information)
Documented Overdose Presentations	Accidental oral ingestion may lead to gastrointestinal symptoms, including abdominal pain, nausea, vomiting, and constipation. Topical overuse is typically associated with local irritation and erythema.
Severe Outcomes	Hypophosphatemia and systemic aluminum toxicity are rare, documented risks from massive or chronic ingestion, particularly in individuals with pre-existing renal impairment.
Management Focus	No specific antidote is known. Management is defined as symptomatic and supportive treatment, often requiring the monitoring of serum phosphate levels and renal function following significant ingestion.

When Immediate Medical Help Is Required

Regulatory guidance explicitly mandates that individuals seek immediate medical attention or contact a poison control center in all cases of suspected or confirmed accidental oral ingestion of the cream. The requirement to seek urgent help is based on the potential for massive exposure to cause systemic effects, primarily affecting the gastrointestinal tract and electrolyte balance. Discontinue topical use if severe local irritation occurs.

Therapeutic Uses of Terkur

What Terkur Treats: Main Uses and Benefits

Terkur is a specialized topical treatment applied in addressing the symptomatic management of excessive perspiration, and provides support for persistent moisture and its related consequences.

Excessive Sweating (Primary Focal Hyperhidrosis)

Terkur is commonly used in conditions presenting with symptoms of primary focal hyperhidrosis—a manifestation where perspiration generally exceeds normal physiological needs in specific body regions, such as the underarms, palms, or feet. The therapeutic approach is relevant in contexts where supportive symptom management is appropriate for addressing hyperhidrosis. It is commonly used to help with the volume of perspiration, which supports the overall symptomatic management of the condition.

“This application is commonly used to help maintain a sense of stability when symptoms of hyperhidrosis interfere with daily comfort.”

Symptomatic Relief from Persistent Wetness and Odor

This treatment is relevant in conditions characterized by periods of heightened symptoms of pronounced and recurrent wetness, and the related symptom of associated body odor (malodor). By promoting dryness, the cream helps address symptom clusters that interfere with daily comfort and supports general well-being during symptomatic phases, particularly concerning odor related to persistent moisture. This application is used for managing physical consequences related to continuous high-volume perspiration, which may include symptoms that interfere with daily functioning, such as difficulty with grip or concerns about skin irritation due to constant dampness. Using the cream may assist with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

Quick Fact: Supportive Relief for Localized Perspiration Symptoms

Eligibility and Restrictions for Use

Who can and cannot use Terkur?

The population eligibility for Terkur (Aluminium Chlorohydrate topical) is defined by official regulatory labeling, establishing groups for whom use is allowed, restricted, or strictly contraindicated.

Contraindications and Restrictions

Terkur must not be used by individuals with a documented hypersensitivity or known allergy to aluminium chlorohydrate or any component of the formulation. Application is strictly restricted to intact skin and must be avoided on broken skin, irritated areas, or skin that has been recently shaven.

Conditional Use Mandate:

Population Group	Regulatory Status
Patients with Kidney Disease (Renal Impairment)	Must consult a health professional before use
Pregnant or Breastfeeding Women	Must consult a health professional before use

Age-Related Eligibility

Use is generally established for the General Adult Population. However, for pediatric patients, safety and efficacy are not established in young children, and use is consequently not recommended in this age group. Use in older adults is generally considered to be the same as for the adult population.

What should I know about interactions with other medicines?

Terkur Interactions with other medicines and products

It is essential to inform your doctor or pharmacist about all medicines you are currently taking or have recently taken, including over-the-counter drugs, herbal supplements, and vitamins. Terkur may interact with several other medications, which could change how the drugs work or increase the risk of side effects.

Potential Drug Interactions

Drug Class	Potential Interaction Effect	Clinical Significance
Anticoagulants/Antiplatelets (e.g., Warfarin, Aspirin, Clopidogrel)	Increased risk of bleeding due to additive anti-clotting effects.	High - Close monitoring and dose adjustment are necessary.
Cytochrome P450 (CYP) Substrates (e.g., Amiodarone, Statins, Antidepressants)	Terkur can be an inhibitor of certain CYP enzymes (specifically CYP3A4, CYP2D6, and CYP2C19), potentially increasing the concentration of these co-administered drugs in the blood and raising the risk of toxicity.	Moderate to High - Dosage adjustments and monitoring of drug levels may be required.
Hypoglycemic Agents (e.g., Insulin, Metformin, Sulfonylureas)	May potentiate the blood sugar-lowering effect, increasing the risk of hypoglycemia (low blood sugar).	Moderate - Blood glucose levels should be monitored closely.

Other Interactions

Grapefruit Juice: Concurrent consumption may increase the blood concentration of Terkur, leading to a higher risk of side effects.
Alcohol: Use with alcohol is not recommended as it may enhance certain side effects, such as dizziness or drowsiness.

Always seek personalized medical advice before starting, stopping, or changing the dosage of any medicine.

Mechanism of Action

Terkur, containing Aluminum Chlorohydrate (ACH) and Salicylic Acid, exerts its action primarily by modulating eccrine gland function and epithelial cell dynamics. The active aluminum salt complex Al2 Cl( OH)5, upon application, interacts directly with the keratin filaments within the distal portion of the eccrine sweat ducts (acrosyringium).

This interaction involves the precipitation of aluminum-protein complexes, which form a physical occlusive plug within the ductal lumen. This occlusion effectively blocks the luminal pathway, preventing the efflux of glandular secretions to the stratum corneum surface. The sustained presence of this physical barrier leads to functional and structural degeneration (atrophy) of the glandular secretory cells, thus reducing the overall secretory capacity of the eccrine acini over time. The co-formulation with Salicylic Acid, a keratolytic agent, facilitates deeper percutaneous penetration of the aluminum salts by disrupting the intercellular cement of the stratum corneum, enhancing the physical blockade and subsequent glandular modulation. The net physiological consequence is a direct mechanical antagonism of eccrine secretory output, resulting in the localized and systemic reduction of fluid accumulation on the skin surface.

Dosage and Administration Information

How to Use Terkur

This section describes the administration and usage patterns for topical antiperspirant preparations, such as Terkur.

Official Administration Guidelines

Usage Principle	Administration Detail
Route of Administration	Application is strictly topical (dermal), intended for external use only.
Dosing Schedule Pattern	Usage begins with an initial phase of once daily application, which transitions to an intermittent maintenance schedule once sufficient perspiration control is established.
Timing and Removal	The cream is applied at night before sleep and must remain on the skin for six to eight hours. The application site must be washed clean with soap and water the following morning.
Pre-Application Condition	The area intended for application must be completely and thoroughly dry prior to using the cream to ensure proper function.
Application Constraints	Application is restricted to the affected skin area only. The cream must be avoided on skin that is broken, irritated, or recently shaved (e.g., within 12 hours).
Age-Group Use	Safety and efficacy for use in pediatric patients (infants and children) have not been established.

Official Use Protocol

Administration of this topical preparation follows a distinct procedural sequence. The use protocol is structured around a short-term, higher-frequency induction phase followed by a long-term, lower-frequency intermittent pattern to sustain the effect. This regimen necessitates the proper topical route and specific nighttime timing to ensure correct administration. The instructions also mandate that the skin is dry before application and is cleansed after the required overnight duration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Terkur

Evidence for Use in Underarm (Axillary) Hyperhidrosis

Research exploring topical agents that have been studied for excessive perspiration, including aluminum salts, has primarily focused on the underarm area. Studies conducted in this field include randomized controlled trials (RCTs) and systematic reviews. These studies monitored how symptoms changed over time in adults diagnosed with primary focal hyperhidrosis.

The outcomes that researchers used to measure changes included objective measures such as gravimetric analysis, which is used in research to estimate sweat volume, and the iodine-starch test, which is used to map the area of sweating. They also used patient-reported outcomes, describing perceived discomfort and reflecting daily functioning. Studies report patterns related to how symptoms were recorded in the observed populations, and findings describe patterns observed in trials involving higher-concentration aluminum chloride (AC) formulations.

What remains uncertain is that the evidence is generally of moderate certainty, and many key trials focused on higher concentrations of a related ingredient, aluminum chloride hexahydrate solution, rather than the aluminum chlorohydrate cream in Terkur. This means the applicability of those specific results to an Aluminium Chlorohydrate cream formulation like Terkur remains uncertain.

Evidence for Use in Hand and Foot (Palmar and Plantar) Hyperhidrosis

Fewer controlled studies were evaluated for applying topical aluminum salts to the hands and feet compared to the underarm area. Research here consists primarily of smaller controlled studies and case series. Research examined the application of aluminum salts and recorded any associated changes in the sweating rate in the hands and feet.

Findings describe patterns where the palmar and plantar sites showed less consistency in measured outcomes when compared to the axillary site. Studies reported some measured changes during the study period, but the results often required the use of higher concentrations of aluminum chloride to achieve those observations. The available evidence is noted by scientific bodies to have lower certainty when evaluating topical treatments for the palm and sole areas.

Evidence Gaps and Areas of Uncertainty

Research has primarily been conducted on adults. The evidence base for using this class of topical treatments in adolescents and other specific patient groups has limited data available. A primary limitation across the research is the heterogeneity of the formulations studied, meaning comparative evidence is lacking when attempting to apply specific findings directly to all products in this category.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Terkur (FAQ)

Q: What is Terkur indicated for?

A: Terkur is a prescription medication that has been approved by regulatory bodies for the management of symptoms associated with chronic, moderate-to-severe inflammatory bowel conditions. Its use is typically considered when standard first-line therapies have not achieved adequate disease control.

Q: How does Terkur work?

A: Terkur is believed to modulate the body’s immune response. Its main action involves interfering with specific pathways that contribute to inflammation. Studies suggest that this mechanism may help to reduce the inflammatory activity central to the target condition.

Q: What should I discuss with my healthcare provider before starting Terkur?

A: It is important to inform your healthcare provider about all of your medical conditions, including any history of infections, cancer, or heart problems. You should also discuss any recent vaccinations or planned surgical procedures. Reviewing all other medications and supplements you currently take is also essential.

Q: Are there common side effects associated with Terkur?

A: Clinical trial data indicates that some common side effects observed in participants included headache, nausea, and minor injection site reactions. A less common but more serious observation in some studies was an increased risk of infection. Your healthcare provider can discuss the complete safety profile based on clinical evidence.

Q: Is Terkur a cure for inflammatory bowel conditions?

A: No. Terkur is not considered a cure. It is a treatment designed to help control symptoms and manage the disease course. Consistent use, as determined by your provider, may help maintain a state of reduced disease activity, but it does not eliminate the underlying condition.

How should Terkur be stored and disposed of?

How to Store and Dispose of Terkur?

The storage and disposal requirements for Terkur are defined by regulatory authorities to ensure product stability and safety.

Requirement	Official Regulatory Statement
Storage Temperature	Store at room temperature, typically below a maximum of 25 C or 30 C, depending on the labeled limit.
Handling / Container	Keep the container tightly closed when not in use. Store the product in its original container and keep it away from excessive heat or ignition sources.
Child Safety	Keep out of the sight and reach of children.
Disposal Rule	Unused or expired product must not be thrown into household waste or flushed down the toilet. Dispose of the product through local pharmaceutical take-back programs or as advised by a pharmacist.

The official labeling mandates that the product be maintained within controlled ambient temperatures and protected from environmental factors like heat and moisture. Disposal must adhere to environmental regulations for pharmaceutical waste, ensuring safe and appropriate discarding of the unused cream.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Turkey

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z